Should referral for [esketamine] come before in-house [quetiapine] augmentation? The NU676 Unit 7 appraisal reads ESCAPE-TRD against that clinic question and returns a qualified yes. Searches like "nu 676 unit 7 assignment example", "nu676 unit 7 sample" and "nu676 unit 7 example" land here.
What a finished NU676 Unit 7 journal club appraisal looks like
A one-page handout and about [1,200] words of appraisal. The handout states the clinic's question in PICO form, the citation, the design in a line, and the verdict. CASP's checklist for randomized trials organizes the appraisal in three movements: are the results valid, what are they, and will they help locally. Validity notes randomization with blinded raters but open-label treatment, and a primary outcome, remission at eight weeks, that counted anyone who stopped treatment as not remitted, while more participants stopped in the [quetiapine] arm. Results report the direction and size of the remission difference and the relapse-free secondary outcome. Applicability addresses the REMS requirement for a certified setting and two hours of observation after each dose, travel for patients, and manufacturer funding. The verdict closes the appraisal.
How a NU676 Unit 7 example is structured
The appraisal starts from the clinic's question rather than the paper's, so every judgment asks whether this trial ought to alter the clinic's practice. PICO frames the question: adults with depression unresponsive to two or more antidepressants, referral for [esketamine], compared with starting [quetiapine] augmentation in house, and remission as the outcome that matters. CASP supplies the order of scrutiny. The validity section treats the handling of dropouts as the most consequential design choice and explains, without jargon, why counting discontinuation as failure favors the better-tolerated arm while still reflecting real practice. Results keep to what the paper reports. Applicability is where the clinic's own constraints enter: no certified site in-house, a [45]-minute drive to the nearest one, and patients who cannot lose a half day twice weekly. The verdict follows from all three.
The clinic's question in PICO form
The clinic's population, intervention, comparison and outcome come before the paper is introduced. Framing the appraisal around a local decision stops it from drifting into a restatement of the abstract, a trap many first appraisals fall into.
Dropouts as the pivotal design choice
Participants who stopped treatment were counted as not remitted, and more stopped in the comparison arm. The appraisal explains that this choice favors the better-tolerated drug and argues it is still fair, since tolerability is part of whether a treatment works in practice.
Open-label, with blinded raters
Patients and clinicians knew which treatment was given, while the raters scoring depression did not. The appraisal weighs how much that protects the primary outcome and where expectation could still have shaped reported improvement. Its answer: substantially, though not completely.
A certified site across the county
Applicability turns on logistics the trial did not face: the REMS requirement that each dose be given in a certified setting with at least two hours of monitoring, and the clinic's patients, many of whom work hourly jobs.
A qualified yes
The verdict recommends offering referral at the same decision point as in-house augmentation, rather than only after it fails, while naming what would change the answer: an independent replication or a certified site closer to the clinic.
Where marks go in NU676 Unit 7
A practice question, answered, is what earns credit in a journal club appraisal for this rotation. An appraisal that summarizes methods and results and never says whether the clinic should change anything has done the reading, not the appraisal. Validity is judged on the flaws that matter for this trial: missing the open-label design, or the way discontinuation was counted, costs more than omitting a minor detail. Reporting only that a difference was significant, without its size, weakens the results section. Applicability is where many drafts go thin, and a recommendation that ignores the monitoring requirement for this drug reads as unrealistic. Funding should be noted without being treated as disqualifying. Citation errors, unexplained jargon and a verdict that does not follow from the analysis before it draw smaller deductions.
Get a NU676 Unit 7 example written to your instructions
Send the paper your NU676 Unit 7 journal club assigns, or its citation, plus the clinic question your preceptor raised if there is one, and the rubric. A free first appraisal arrives in 24-48h, framed around that question, with a handout for the room and a verdict on whether the clinic should change what it does.
NU676 Unit 7 questions, answered
What is ESCAPE-TRD?
A randomized, open-label trial with blinded raters, reported in 2023 by Reif and colleagues in the New England Journal of Medicine. Adults with treatment-resistant depression, continuing an SSRI or SNRI, received either [esketamine] nasal spray or [extended-release quetiapine]. The primary outcome was remission at eight weeks, with a longer relapse-free outcome as a key secondary measure. The manufacturer of [esketamine] funded it.
Why does the appraisal start from a clinic question?
Because journal club in a clinical rotation exists to inform practice. A question such as whether to refer before trying augmentation gives every part of the appraisal a purpose: validity matters as far as it affects that decision, and applicability becomes the deciding section. Without a question, an appraisal tends to drift into a summary nobody can act on.
Does industry funding invalidate a trial?
No, but it deserves a note. Many pivotal trials are manufacturer-funded, and the appraisal checks the design choices funding could influence, such as the comparator, its dosing and the outcome definitions. A fair appraisal records the funding, looks for those specific effects and judges the trial on its methods rather than dismissing it or ignoring the source.